TrialJAMA oncology2021

Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Randomized Clinical Trial.

Leora Horn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.